Gritstone bio, Inc.
7 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of an Individualized Vaccine Targeting Neoantigens in Combination With Immune Checkpoint Blockade for Patients With Colon Cancer (NCT05456165) | Gritstone bio, Inc. | 2022-05-19 |
| Study of Self-Amplifying Messenger Ribonucleic Acid (samRNA) Vaccines Against COVID-19 in Healthy Adults and People Living With Human Immunodeficiency Virus (HIV) (NCT05435027) | Gritstone bio, Inc. | 2022-02-28 |
| A Screening Study Targeting Tumor-specific Antigens (NCT05158621) | Gritstone bio, Inc. | 2021-12-14 |
| Study of GRT-R910 COVID-19 Boost Vaccine in Healthy Volunteers (NCT05148962) | Gritstone bio, Inc. | 2021-09-16 |
| A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens (NCT03953235) | Gritstone bio, Inc. | 2019-07-18 |
| A Study of a Personalized Neoantigen Cancer Vaccine (NCT03639714) | Gritstone bio, Inc. | 2019-02-13 |
| A Study of Personalized Neoantigen Cancer Vaccines (NCT03794128) | Gritstone bio, Inc. | 2018-07-25 |
Track Gritstone bio, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.